The risk of arrhythmias and sudden cardiac death significantly affected medium and long-term outcomes in heart transplant (HT) recipients, who were a special and susceptible population. Data from the National Inpatient Sample from 2009 to 2018 were examined retrospectively. Patients who underwent HT or who have had HT and received newly implanted cardioverter-defibrillators (ICDs) were included in the hospitalization data (excluding the preexisting ICD). Read more in Physician’s Weekly.
Utilization of Implantable Cardioverter-Defibrillators in Patients with Heart Transplant
